RESTON, Va.--(BUSINESS WIRE)--Oct. 26, 2009-- QuadraMed® Corporation (NASDAQ:QDHC) today announced that three health systems in the U.S., and one healthcare organization based in Toronto, Canada have licensed QuadraMed CPR (QCPR). QCPR is an enterprise-wide computerized patient record and electronic health record system that includes closed-loop medication management, Computerized Physician Order Entry (CPOE), clinical decision support, and integrated laboratory and radiology management systems. QCPR includes a multi-entity, patient-centric database and has achieved significant market recognition through its numerous awards and long-standing client base.
The three U.S. healthcare organizations plan to use QCPR to help enable them to receive funding under the American Recovery and Reinvestment Act of 2009 (ARRA) and the Health Information Technology for Economic and Clinical Health (HITECH) act. QCPR has a proven track record of gaining high levels of clinician adoption with CPOE and integrated medication management. QCPR will help enable these clients to automate their clinical operations in order to better meet future requirements of the ARRA and HITECH acts.
"As the momentum of EHR adoption continues, we are pleased to support each of these health systems in their quest to improve their clinical quality and efficiency. I'm also pleased that our solutions will assist the three U.S. hospitals in their efforts to secure ARRA and HITECH funds," said Duncan W. James, QuadraMed's President and CEO. "In coming years, the ‘meaningful use' criteria may require hospitals to demonstrate extensive CPOE deployment in order to receive the maximum value of these funds," he added. "QuadraMed's QCPR clients in the U.S. and in Canada have deployed our CPOE solution extensively for years, and these four new contracts help to validate QCPR as a proven and functionally robust EHR."
New QCPR clients include:
- Hunterdon Medical Center (http://www.hunterdonhealthcare.org), Flemington, N.J. - The 178-bed medical center provides comprehensive medical, diagnostic, surgical, behavioral health, rehabilitative and preventive health services for inpatients and outpatients. In addition to QCPR, including CPOE and Barcode Medication Administration, Hunterdon Medical Center also licensed QuadraMed Enterprise Scheduling and AcuityPlus.
- Galion Hospital (http://www.galionhospital.org), Galion, Ohio - The critical access hospital offers 25 acute care beds and a 10 bed in-patient rehabilitation unit. In addition to QCPR, including CPOE and Barcode Medication Administration, Galion Hospital also licensed QuadraMed Enterprise Scheduling (QES), QuadraMed Electronic Document Management (QEDM) and AcuityPlus.
- Summa Health System-Barberton Hospital (http://www.barbhosp.com), Barberton, Ohio - The 311-bed, general acute care community hospital supplies inpatient services in the clinical areas of medicine, surgery, cardiology, critical care, extended care, psychiatry, oncology, emergency medicine, obstetrics and physical rehabilitation. In addition to QCPR, including CPOE and Barcode Medication Administration, Barberton Hospital also licensed AcuityPlus.
- Toronto Rehabilitation Institute (http://www.torontorehab.on.ca/), Toronto, Ontario, Canada - Toronto Rehab is a 200-bed, fully-affiliated teaching and research hospital of the University of Toronto. Toronto Rehab, an extension of the University Healthcare Network (UHN), licensed QCPR to enable consistent patient treatment documentation within the same EHR across the UHN healthcare system. Toronto Rehab also licensed AcuityPlus.
About QuadraMed Corporation
QuadraMed® (NASDAQ:QDHC) is a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes. QuadraMed provides innovative solutions that streamline processes, ensure compliance and help healthcare professionals deliver quality patient care. Behind the Company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com.
Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words "believe," "expect," "target," "goal," "project," "anticipate," "predict," "intend," "plan," "estimate," "may," "will," "should," "could" and similar expressions and their negatives are intended to identify such statements. Forward-looking statements are not guarantees of future performance, anticipated trends or growth in businesses, or other characterizations of future events or circumstances and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by QuadraMed described in documents filed with the Securities and Exchange Commission ("SEC") from time to time. QuadraMed's SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC's EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.
Source: QuadraMed Corporation
Amendola Communications for QuadraMed Corporation
Kate Donlon
619-876-2654
[email protected]
or
QuadraMed Corporation
Investor Relations
703-742-5393
[email protected]